Acute mountain sickness, inflammation, and permeability: New insights from a blood biomarker study

Journal of Applied Physiology

Volumn 111, Issue 2, 2011, Pages 392-399

  Julian, Colleen Glyde ^a   Subudhi, Andrew W ^a,b   Wilson, Megan J ^a   Dimmen, Andrew C ^a   Pecha, Travis ^a   Roach, Robert C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Cerebral edema; Headache; High altitude; Hypoxia; Inflammatory

Indexed keywords

ACETAZOLAMIDE; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE INHIBITOR; DEXAMETHASONE;

ACUTE DISEASE; ADULT; ALTITUDE; ALTITUDE DISEASE; ARTICLE; BLOOD; BLOOD BRAIN BARRIER; BRAIN EDEMA; CELL MEMBRANE PERMEABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEADACHE; HUMAN; INFLAMMATION; MALE; MOUNTAINEERING; PATHOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ACETAZOLAMIDE; ACUTE DISEASE; ADULT; ALTITUDE; ALTITUDE SICKNESS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CARBONIC ANHYDRASE INHIBITORS; CELL MEMBRANE PERMEABILITY; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; INFLAMMATION; MALE; MOUNTAINEERING; YOUNG ADULT;

EID: 80051738673     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00391.2011     Document Type: Article

References (55)

1. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 20: 131-147, 2000. (Pubitemid 30091452)
2. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53, 2006. (Pubitemid 41828930)
3. Bailey DM, Kleger GR, Holzgraefe M, Ballmer PE, Bartsch P. Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness. J Appl Physiol 96: 1459-1463, 2004 (Pubitemid 38392684)
4. Basnyat B, Murdoch DR. High-altitude illness. Lancet 361: 1967-1974, 2003. (Pubitemid 36694589)
5. Coakley RJ, Taggart C, Greene C, McElvaney NG, O'Neill SJ. Ambient pCO2 modulates intracellular pH, intracellular oxidant generation, and interleukin-8 secretion in human neutrophils. J Leukoc Biol 71: 603-610, 2002.
6. Cormier-Regard S, Nguyen SV, Claycomb WC. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 273: 17787-17792, 1998. (Pubitemid 28355122)
7. Cucullo L, Hallene K, Dini G, Dal Toso R, Janigro D. Glycerophosphoinositol and dexamethasone improve transendothelial electrical resistance in an in vitro study of the blood-brain barrier. Brain Res 997: 147-151, 2004. (Pubitemid 38058519)
8. Dossus L, Becker S, Achaintre D, Kaaks R, Rinaldi S. Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. J Immunol Methods 350: 125-132, 2009.
9. Fischer S, Renz D, Schaper W, Karliczek GF. In vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor. Eur J Pharmacol 411: 231-243, 2001. (Pubitemid 32119593)
10. Giffard RG, Yenari MA. Many mechanisms for hsp70 protection from cerebral ischemia. J Neurosurg Anesthesiol 16: 53-61, 2004. (Pubitemid 38057399)
11. Guerrero JA, Vicente V, Corral J. Dexamethasone induction of a heat stress response. Methods Enzymol 490: 121-135.
12. Hackett P, Roach RC. High-altitude illness. N Engl J Med 345: 107-114, 2001. (Pubitemid 32634570)
13. Hackett PH, Roach RC, Wood RA, Foutch RG, Meehan RT, Rennie D, Mills WJJ. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 59: 950-954, 1988.
14. Haditsch B, Roessler A, Hinghofer-Szalkay HG. Renal adrenomedullin and high altitude diuresis. Physiol Res 56: 779-787, 2007.
15. Hartmann G, Tschop M, Fischer R, Bidlingmaier C, Riepl R, Tschop K, Hautmann H, Endres S, Toepfer M. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine 12: 246-252, 2000. (Pubitemid 30449882)
16. Hofbauer KH, Jensen BL, Kurtz A, Sandner P. Tissue hypoxygenation activates the adrenomedullin system in vivo. Am J Physiol Regul Integr Comp Physiol 278: R513-R519, 2000. (Pubitemid 30129644)
17. Honda M, Nakagawa S, Hayashi K, Kitagawa N, Tsutsumi K, Nagata I, Niwa M. Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5. Cell Mol Neurobiol 26: 109-118, 2006. (Pubitemid 43881818)
18. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24: 719-725, 2001. (Pubitemid 33097539)
19. Imai T, Hirata Y, Iwashina M, Marumo F. Hormonal regulation of rat adrenomedullin gene in vasculature. Endocrinology 136: 1544-1548, 1995.
20. Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325: 253-257, 1987. (Pubitemid 17049884)
21. Kallenberg K, Bailey DM, Christ S, Mohr A, Roukens R, Menold E, Steiner T, Bartsch P, Knauth M. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab 27: 1064-1071, 2007. (Pubitemid 46659029)
22. Kawaai H, Seino H, Yamazaki S, Taki K. Changes in leukocyte migration during carbonic anhydrase activity inhibition. Burns 35: 397-404, 2009.
23. Kis B, Snipes JA, Deli MA, Abraham CS, Yamashita H, Ueta Y, Busija DW. Chronic adrenomedullin treatment improves blood-brain barrier function but has no effects on expression of tight junction proteins. Acta Neurochir Suppl (Wien) 86: 565-568, 2003.
24. Klausen T, Olsen NV, Poulsen TD, Richalet JP, Pedersen BK. Hypoxemia increases serum interleukin-6 in humans. Eur J Appl Physiol Occup Physiol 76: 480-482, 1997. (Pubitemid 27458422)
25. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 102: 1313-1322, 2007. (Pubitemid 46571023)
26. Macmanus CF, Campbell EL, Keely S, Burgess A, Kominsky DJ, Colgan SP. Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization. FASEB J 25: 1856-1864, 2011.
27. Matsuzawa Y, Kobayashi T, Fujimoto K, Shinozaki S, Yoshikawa S. Cerebral edema in acute mountain sickness. In: High Altitude Medicine, edited by Ueda G, Reeves JT, and Sekiguchi M. Matsumoto, Japan: Shinshu University Press, 1992, p. 300-304.
28. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367, 2006.
29. Minamino N, Shoji H, Sugo S, Kangawa K, Matsuo H. Adrenocortical steroids, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 211: 686-693, 1995.
30. Miyashita K, Itoh H, Arai H, Suganami T, Sawada N, Fukunaga Y, Sone M, Yamahara K, Yurugi-Kobayashi T, Park K, Oyamada N, Taura D, Tsujimoto H, Chao TH, Tamura N, Mukoyama M, Nakao K. The neuroprotective and vasculo-neuro- regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. Endocrinology 147: 1642-1653, 2006.
31. Moldow B, Sander B, Larsen M, Lund-Andersen H. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB. Invest Ophthalmol Vis Sci 40: 1770-1775, 1999. (Pubitemid 29297153)
32. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140: 471-476, 2003. (Pubitemid 37330491)
33. Nakayama M, Takahashi K, Murakami O, Shirato K, Shibahara S. Induction of adrenomedullin by hypoxia in cultured human coronary artery endothelial cells. Peptides 20: 769-772, 1999. (Pubitemid 29378341)
34. Prat A, Biernacki K, Wosik K, Antel JP. Glial cell influence on the human blood-brain barrier. Glia 36: 145-155, 2001. (Pubitemid 33055903)
35. Reid L, Carter K, Ellsworth A. Acetazolamide or dexamethasone for prevention of acute mountain sickness: a meta-analysis. J Wilderness Med 5: 34-48, 1994. (Pubitemid 24156615)
36. Roach RCBP, Hackett P, Oelz O. The Lake Louise acute mountain sickness scoring system. In: Hypoxia and Molecular Medicine. Burlington, VT: Queen City Printers, 1993, p. 272-274.
37. Roach RC, Icenogle M, Hinghofer-Szalkay H, Maes D, Sandoval D, Robergs R, Lium D, Loeppky JA. Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol 88: 581-585, 2000. (Pubitemid 30097102)
38. Rothwell N. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun 17: 152-157, 2003. (Pubitemid 36434364)
39. Schoonman GG, Sandor PS, Nirkko AC, Lange T, Jaermann T, Dydak U, Kremer C, Ferrari MD, Boesiger P, Baumgartner RW. Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 28: 198-206, 2008.
40. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
41. Sirovskiy E, Kornienko V, Moshkin A, Amcheslavskiy V, Ingorokva G, Glazman L. VPF and interstitial fluid pressure in brain oedema. Acta Neurochir Suppl (Wien) 51: 411-413, 1990.
42. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl (Wien) 96: 444-450, 2006.
43. Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, Andjelkovic AV. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 25: 593-606, 2005. (Pubitemid 40562932)
44. Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol 279: L419-L422, 2000.
45. Subudhi AW, Dimmen AC, Julian CG, Wilson MJ, Panerai RB, Roach RC. Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia. J Appl Physiol 110: 1219-1225, 2011.
46. Subudhi AW, Panerai RB, Roach RC. Effects of hypobaric hypoxia on cerebral autoregulation. Stroke 41: 641-646.
47. Swenson ER, MacDonald A, Vatheuer M, Maks C, Treadwell A, Allen R, Schoene RB. Acute mountain sickness is not altered by a high carbohydrate diet nor associated with elevated circulating cytokines. Aviat Space Environ Med 68: 499-503, 1997. (Pubitemid 27251698)
48. Watanabe K, Takayasu M, Noda A, Hara M, Takagi T, Suzuki Y, Yoshia J. Adrenomedullin reduces ischemic brain injury after transient middle cerebral artery occlusion in rats. Acta Neurochir (Wien) 143: 1157-1161, 2001. (Pubitemid 33078443)
49. West MA, LeMieur TL, Hackam D, Bellingham J, Claire L, Rodriguez JL. Acetazolamide treatment prevents in vitro endotoxin-stimulated tumor necrosis factor release in mouse macrophages. Shock 10: 436-441, 1998. (Pubitemid 128463867)
50. Wilson MH, Milledge J. Direct measurement of intracranial pressure at high altitude and correlation of ventricular size with acute mountain sickness: Brian Cummins' results from the 1985 Kishtwar expedition. Neurosurgery 63: 970-974; discussion 974-975, 2008.
51. Wolk R, Svatikova A, Otto ME, Hoffmann MS, Duenwald CJ, Somers VK. Plasma adrenomedullin and obstructive sleep apnea. Am J Hypertens 17: 74-76, 2004. (Pubitemid 38064764)
52. Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Hum Gene Ther 15: 1243-1254, 2004. (Pubitemid 40052436)
53. Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Exp Neurol 197: 521-530, 2006. (Pubitemid 43077160)
54. Yenari MA, Liu J, Zheng Z, Vexler ZS, Lee JE, Giffard RG. Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann N Y Acad Sci 1053: 74-83, 2005. (Pubitemid 43031084)
55. Zhang K, Zhao T, Huang X, Liu ZH, Xiong L, Li MM, Wu LY, Zhao YQ, Zhu LL, Fan M. Preinduction of HSP70 promotes hypoxic tolerance and facilitates acclimatization to acute hypobaric hypoxia in mouse brain. Cell Stress Chaperones 14: 407-415, 2009.